FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080883339> ?p ?o ?g. }

• W2080883339 endingPage "230" @default.
• W2080883339 startingPage "225" @default.
• W2080883339 abstract "Chronic liver disease caused by hepatitis C virus (HCV) seems to present a more accelerated course in HIV-infected patients, leading to cirrhosis and liver failure in a shorter period of time than in HIV-negative individuals. As efforts to increase life expectancy in HIV-infected people progress, substantial morbidity and mortality from HCV infection is likely to arise amongst subjects infected parenterally, such as injecting drug users, haemophiliacs and transfusion recipients. Preliminary results have suggested that alpha-interferon (IFN) treatment allows higher rates of response in HIV-infected patients with higher CD4+ lymphocyte counts, suggesting a primary dependence of IFN on a preserved immune system in order to act appropriately. In an open, multicentre, prospective trial we analysed whether the use of larger doses of IFN, through an escalating schedule, might overcome the limits imposed by immune dysfunction. An interim analysis performed in 29 patients concluded that escalating the dosage did not improve the rate of response to IFN. In fact, only one (8.3%) out of 12 patients without response after 3 months of being on IFN therapy achieved response after the dosage was increased from 5 MU to 8 MU s.c. three times a week. Moreover, he relapsed 3 months after completion of treatment for 1 year." @default.
• W2080883339 created "2016-06-24" @default.
• W2080883339 creator A5008407169 @default.
• W2080883339 creator A5009751300 @default.
• W2080883339 creator A5013620258 @default.
• W2080883339 creator A5013910120 @default.
• W2080883339 creator A5014251604 @default.
• W2080883339 creator A5027520171 @default.
• W2080883339 creator A5043500393 @default.
• W2080883339 creator A5051614036 @default.
• W2080883339 creator A5056870679 @default.
• W2080883339 date "1997-11-01" @default.
• W2080883339 modified "2023-10-13" @default.
• W2080883339 title "A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients" @default.
• W2080883339 cites W1648420719 @default.
• W2080883339 cites W1654040128 @default.
• W2080883339 cites W1714653869 @default.
• W2080883339 cites W1972036658 @default.
• W2080883339 cites W1975358618 @default.
• W2080883339 cites W1978073437 @default.
• W2080883339 cites W1981367536 @default.
• W2080883339 cites W1990425795 @default.
• W2080883339 cites W1990480905 @default.
• W2080883339 cites W1993262285 @default.
• W2080883339 cites W2001637887 @default.
• W2080883339 cites W2018370670 @default.
• W2080883339 cites W2019943793 @default.
• W2080883339 cites W2023083968 @default.
• W2080883339 cites W2030425973 @default.
• W2080883339 cites W2053583159 @default.
• W2080883339 cites W2053741409 @default.
• W2080883339 cites W2056426324 @default.
• W2080883339 cites W2063089198 @default.
• W2080883339 cites W2086063014 @default.
• W2080883339 cites W2092649376 @default.
• W2080883339 cites W2107414185 @default.
• W2080883339 cites W2115956200 @default.
• W2080883339 cites W2117143503 @default.
• W2080883339 cites W2117851049 @default.
• W2080883339 cites W2119600310 @default.
• W2080883339 cites W2120527130 @default.
• W2080883339 cites W2150102564 @default.
• W2080883339 cites W2171177822 @default.
• W2080883339 cites W2334197314 @default.
• W2080883339 cites W2409827818 @default.
• W2080883339 cites W2415628739 @default.
• W2080883339 cites W2096189195 @default.
• W2080883339 doi "https://doi.org/10.1016/s0163-4453(97)92776-6" @default.
• W2080883339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9459392" @default.
• W2080883339 hasPublicationYear "1997" @default.
• W2080883339 type Work @default.
• W2080883339 sameAs 2080883339 @default.
• W2080883339 citedByCount "17" @default.
• W2080883339 countsByYear W20808833392017 @default.
• W2080883339 crossrefType "journal-article" @default.
• W2080883339 hasAuthorship W2080883339A5008407169 @default.
• W2080883339 hasAuthorship W2080883339A5009751300 @default.
• W2080883339 hasAuthorship W2080883339A5013620258 @default.
• W2080883339 hasAuthorship W2080883339A5013910120 @default.
• W2080883339 hasAuthorship W2080883339A5014251604 @default.
• W2080883339 hasAuthorship W2080883339A5027520171 @default.
• W2080883339 hasAuthorship W2080883339A5043500393 @default.
• W2080883339 hasAuthorship W2080883339A5051614036 @default.
• W2080883339 hasAuthorship W2080883339A5056870679 @default.
• W2080883339 hasConcept C126322002 @default.
• W2080883339 hasConcept C133925201 @default.
• W2080883339 hasConcept C140206745 @default.
• W2080883339 hasConcept C203014093 @default.
• W2080883339 hasConcept C2522874641 @default.
• W2080883339 hasConcept C2776178377 @default.
• W2080883339 hasConcept C2776408679 @default.
• W2080883339 hasConcept C2776455275 @default.
• W2080883339 hasConcept C2777075537 @default.
• W2080883339 hasConcept C2777214474 @default.
• W2080883339 hasConcept C2781228144 @default.
• W2080883339 hasConcept C2908647359 @default.
• W2080883339 hasConcept C2909179924 @default.
• W2080883339 hasConcept C3013748606 @default.
• W2080883339 hasConcept C71924100 @default.
• W2080883339 hasConcept C8891405 @default.
• W2080883339 hasConcept C90924648 @default.
• W2080883339 hasConcept C99454951 @default.
• W2080883339 hasConceptScore W2080883339C126322002 @default.
• W2080883339 hasConceptScore W2080883339C133925201 @default.
• W2080883339 hasConceptScore W2080883339C140206745 @default.
• W2080883339 hasConceptScore W2080883339C203014093 @default.
• W2080883339 hasConceptScore W2080883339C2522874641 @default.
• W2080883339 hasConceptScore W2080883339C2776178377 @default.
• W2080883339 hasConceptScore W2080883339C2776408679 @default.
• W2080883339 hasConceptScore W2080883339C2776455275 @default.
• W2080883339 hasConceptScore W2080883339C2777075537 @default.
• W2080883339 hasConceptScore W2080883339C2777214474 @default.
• W2080883339 hasConceptScore W2080883339C2781228144 @default.
• W2080883339 hasConceptScore W2080883339C2908647359 @default.
• W2080883339 hasConceptScore W2080883339C2909179924 @default.
• W2080883339 hasConceptScore W2080883339C3013748606 @default.
• W2080883339 hasConceptScore W2080883339C71924100 @default.
• W2080883339 hasConceptScore W2080883339C8891405 @default.

• next